Andrew McGuire, PhD

faculty member

Andrew McGuire, PhD

Associate Professor, Immunology and Vaccine Development Program
Vaccine and Infectious Disease Division, Fred Hutch

Fax: 206.667.7767
Mail Stop: E5-110

Dr. Andrew McGuire is a molecular and cellular biologist who works on the design of HIV vaccines. His research is focused on developing immunogens — molecules that would cause the immune system to generate protective proteins, or neutralizing antibodies, to block the virus. Because HIV mutates so rapidly, conventional antibodies do not provide lasting protection. So, Dr. McGuire is working on coaxing the immune system to generate so-called broadly neutralizing antibodies, which are difficult for HIV to evade and more effective at protecting against different strains. His lab also works on the design of vaccines against Epstein-Barr virus, which can cause mononucleosis and certain cancers.


PhD, Molecular and Cellular Biology, University of Guelph, Ontario, 2011

BSc, Molecular Biology and Genetics, University of Guelph, 2004

Research Interests

HIV-1 Immunogen Design

Development of Broadly Neutralizing Antibodies in HIV-1 Infection

Antigen-B cell interactions

Current Projects

Developing, producing, and assessing novel immunogens to elicit broadly neutralizing antibodies against HIV-1

Developing and testing vaccines against Epstein-Barr virus

"There is a lot of emphasis in my work on structures and antibodies, but the ultimate goal is to use what we learn from those to try and make vaccines, or better vaccines."

— Dr. Andrew McGuire

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210